The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
One of the compounds it's like ebo it's called FG for 592 it's a small molecule that blocks one of the prolyl hydroxylase is missing it tricks the system into thinking about its hypoxic and you end up producing more Ipoh that drug was in clinical trials and before the drug was even approved it was being used by cyclists
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.